According to FutureWise analysis, the genome editing market in 2025 is US$6.15 billion, and is expected to reach US$30.91 billion by 2033 at a CAGR of 22.36%.
The increasing support from governments worldwide for research into genome editing technologies is a key driver behind the growing market for genetically modified plants. This support has led to significant advancements in agricultural biotechnology, allowing scientists to develop crops that are more resilient to pests, diseases, and environmental stressors. Additionally, the rise in genetically modified organisms (GMOs) is matched by the growing prevalence of chronic diseases, such as cancer, which has created a demand for more nutritious and disease-resistant food sources. As public awareness of the potential benefits of GMOs continues to increase, along with the need for sustainable agricultural practices, the market is positioned for strong growth. Moreover, collaborations between the private sector and research institutions are fostering innovative solutions that address both food security and health challenges, further enhancing the appeal of genome editing in modern agriculture. Overall, government support for genome editing research and the rising prevalence of chronic diseases like cancer are significant factors driving market growth.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Genome Editing Market trends that shall affect the overall market growth.
Request a Free Sample @
https://www.futurewiseresearch.com/contact.aspx?rpt=5822&type=requestsample
By Technology
- CRISPR
- TALEN
- ZFN
- Antisense
- Other Technologies
By Product and Service
- Reagents and Consumables
- Software and Systems
- Services
By Application
- Genetic Engineering
- Cell Line Engineering
- Animal Genetic Engineering
- Plant Genetic Engineering
- Diagnostic Applications
- Drug Discovery and Development
- Other Applications
By End-User
- Pharmaceutical Companies
- Biotechnology Companies
- Academic and Government Research Institutes
By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Competitive Landscape in Genome Editing Market:
- Thermo Fisher Scientific
- Merck
- Horizon Discovery
- Genscript
- Sangamo Therapeutics
- Lonza
- Editas Medicine
- Crispr Therapeutics
- Eurofins Scientific
- Precision Biosciences
- Oxford Genetics
- Intellia Therapeutics
- Synthego
- Vigene Biosciences
- Epigenie
- Integrated DNA Technologies
- New England Biolabs
- Origene Technologies
- Transposagen Biopharmaceuticals
- Creative Biogene
Buy now the latest version of this report: https://www.futurewiseresearch.com/checkout.aspx?ReportId=5822&license=multi
**Objectives of this Study: **
- To provide a comprehensive analysis of the Genome Editing Market By Technology, By Product and Service, By Application, By End-User and By Region.
- To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
- To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
- To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Flexible Delivery Model:
- We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
- The customization services offered are free of charge with the purchase of any license of the report.
- You can directly share your requirements/changes to the current table of contents to: [email protected]
